28
May
More John Hunter video clips
For all you John Hunter fans, we’ve posted the final clips from his session at the Evolv 2010 Summit. Subscribe to Evolv’s YouTube Channel to watch the rest of John’s great presentation.
28
May
19
May
John Hunter explains importance of mitochondrial health
Posted By: Jonathan Gilliam - Chief Marketing Officer on May 19, 2010 in Archaea Active, Health, research, Science
Following up on our post of a fantastic video on the science behind Evolv, we continue with new video clips from the on-stage presentation from FutureCeutical’s John Hunter at the Evolv 2010 Summit.
In this clip, Mr. Hunter explains what the “mitochondria” in your body do and why oxygen uptake at the cellular level is so critical to mitochondrial health.
12
May
John Hunter explains the science behind Evolv
Posted By: Jonathan Gilliam - Chief Marketing Officer on May 12, 2010 in Archaea Active, Health, research, Science
We all agree that when we drink Evolv we feel better. We also agree that we’d love for everyone we know to be drinking Evolv so they can feel better too. But how does Evolv work the way it does?
The good news is that you and I need not become experts in molecular biology in order to share Evolv. We just share it, people feel it and get excited about what they feel. Trey has invested millions of dollars in research to provide you with even more confidence in this amazing product, and to develop new ones to further enrich your health and your income.
Those of you who attended the 2010 Summit will recognize John Hunter, VP and General Manager of FutureCeuticals, Inc., our product research and development partner currently researching multiple facets of the ArchaeaActive solution. In this post is the first of four clips from the 2010 Summit of John Hunter explaining the science behind Archaea Active and the research platform we are building to examine how it works.
FutureCeuticals is planning to release their first study on Evolv this year. Thank you John Hunter for your fantastic presentation the Summit. Share this video with friends, play it at your next PER, and get a better sense of why Evolv makes you feel the way you do.
11
May
Science behind Evolv is helping the Gulf oil spill
Posted By: Jonathan Gilliam - Chief Marketing Officer on May 11, 2010 in Archaea Active, Health, research, Science
Several Members have asked if 
EvolvHealth and Health2o Products, manufacturer of the Archaea Active™ formula, are doing anything for the Gulf oil spill.
If you are familiar with the history of our bio-catalyst, you will remember that the Archaea Active™ formula was originally created for bioremediation — cleaning up contamination using live organisms. It was this concept of positive biological stimulation that was manipulated over several years to include only food-grade ingredients, thereby making it safe for human consumption.
The original bio-catalyst is one of several ingredients in a product called PowerClean, to be used in the Gulf clean-up. PowerClean has long been listed on the EPA National Contingency Plan Product Schedule. The patented formula also includes a blend of surfactants and microbes that perform a variety of tasks in contamination cleanup. Integra Environmental has received an initial order for 10,000 gallons of the PowerClean water treatment to test on the spill.
Of course, PowerClean is not the same product as your all-natural Evolv; rest assured we won’t be pouring gallons of Evolv into the Gulf of Mexico. You can be proud, though, that the science that originated the Archaea Active™ formula is aiding in the cleanup efforts.
Developer and marketer of science-driven health products announced today the addition of Mr. Ken Dunn and his business partners, all top earners in the network marketing industry.
Dallas, TX March 5, 2010 – EvolvHealth, LLC developer and marketer of science-driven health products, announced today the addition of Mr. Ken Dunn and his business partners, all top earners in the network marketing industry. Mr. Dunn’s group represents a global community of tens of thousands of individuals focused on improving the quality of its members’ lives while instilling leadership values. After a thorough review of more than 100 companies, Mr. Dunn’s team has chosen to join EvolvHealth.
“The addition of Ken and his colleagues to the Evolv team is a tremendous win for the company and our Members,” said EvolvHealth founder Trey White. “Our team brings a sizable organization focused on developing new leaders at all levels and making a positive difference in people’s health through our products. Their belief in strong character and ethics perfectly aligns them with our ‘give, share, Evolv’ culture.”
“Over the past three weeks, our team of 15 industry veterans conducted an exhaustive review of the network marketing industry,” said Ken Dunn. “Our goal was to find the perfect company with which to partner and rapidly build our community around the world. Evolv was the perfect fit.”
Mr. Dunn went on to say that at the onset of the search the review team established several important criteria in their selection process: 1) a company selling a consumable supplement-based product; 2) a company ideally timed ahead of its momentum phase; 3) a company with significant funding; 4) a company with significant experience in both ownership and management; and 5) a company with a true desire to expand ethically and rapidly into the international arena. Their search included an internet and telephonic review of over 120 opportunities, followed by personal confidential meetings with owners and principals of 19 companies.
“Ken’s team is known and respected internationally within the network marketing business,” said Brent Hicks, EvolvHealth CEO. “Their skills and experience align perfectly with our goal of becoming a global, billion-dollar brand over the next three years.”
“We are excited about this opportunity,” said Mr. Dunn. “Evolv at its early stage is already breaking records in network marketing. Our leaders are especially excited about the ground-breaking research now underway with the product’s Archaea Active formula. Making the decision to join this company was the only decision.”
ABOUT KEN DUNN
Ken Dunn has been in the direct sales industry for the past 7 years and has built organizations of over 130,000 people in 21 countries. Ken is an internationally recognized speaker and authority on the network marketing profession who has traveled the world teaching leadership-based, business-building techniques under the brand http://www.secretsofsimplicity.com.
ABOUT EVOLVHEALTH, LLC
EvolvHealth is a consumer health products company, helping people improve their family’s physical and financial well-being through science-driven products and entrepreneurial opportunities. Headquartered in Dallas, Texas, its flagship product is Evolv, an enhanced water beverage that has been in development for more than 15 years and shown to have multiple health benefits. The product was released in the fall 2009 and is marketed through a network of independent business owners in North America. For more information visit www.evolvhealth.com.
CONTACT INFORMATION:
Jonathan Gilliam
Chief Marketing Officer
EvolvHealth
972-715-6400
media@evolvhealth.com
http://www.blog.evolvhealth.com
http://www.facebook.com/evolvhealth
http://www.twitter.com/theevolver
12
Jan
Great news! Health2o Products LLC, our manufacturing partner, just signed a multi-year, multi-million dollar research and product development agreement with FutureCeuticals Inc. The agreement represents the next phase of research and is a significant investment in the science of the Archaea Active solution. This represents another step in our long-range plans to provide science-backed products to the direct marketing industry.
FutureCeuticals will serve as our research and product development partner as we explore various methods of delivery for the Archaea Active solution. This relationship will enable Evolv to leverage decades of experience in manufacturing health-related products, lending further credibility to Archaea Active. Read on for more info from the Health2o team.
From the Heath2o Products LLC website:
DALLAS, TX (January 5, 2010)—FutureCeuticals®, an internationally respected bio-technology firm, has signed a multi-year, multi-million dollar Cooperative Research and Development Agreement with Health2o Products, LLC of Dallas. Known for their innovations in research and development of consumer health and nutritional products, FutureCeuticals agreed to conduct research on production optimization of the Health2o Archaea Active™ formula and proprietary manufacturing processes. In addition, they will complete extensive, long-range scientific analysis and studies in clinico for the Archaea Active products currently being manufactured and in development by Health2o Products.
Initial product research and in vitro testing has supported the scientific promise of Health2o’s all natural Archaea Active formula. It is believed that the Archaea Active formula is involved with specific cell signaling processes that stimulate other cells to take human health protective responses.
“The preliminary in vitro tests conducted last year suggest that our Archaea Active formula stimulates cellular oxygen uptake and utilization, and may also possess similar metabolic properties as those compounds traditionally associated with healthy inflammatory responses.” said Kevin D. Kuykendall, Chairman and CEO of Health2o Products, LLC. “FutureCeuticals’ research will contribute to our goals for optimizing our technology platform and manufacturing processes. We selected FutureCeuticals because of their experience, specialized manufacturing knowledge, and innovative scientific research and development techniques.”
At the direction of Health2o, FutureCeuticals will initiate advanced chemistry and bio-testing protocols utilizing high-tech analytical tools and published methods. The range of research goals include chemical and physical characterization of the active components within the Archaea Active formula, as well as ex vivo screening followed by exploratory clinical studies to identify its effect and functionality in humans. Studies will target cellular regeneration, oxygen and energy metabolism, and inflammatory responses.
“We quickly recognized that Health2o has assembled a dynamic and talented group of people, and their Archaea Active technology is showing great promise.” said John M. Hunter, General Manager of FutureCeuticals. “We’re excited to have the opportunity to integrate our manufacturing capabilities, scientific knowledge, and experience into the Health2o effort—from the sourcing and standardization of raw materials and the optimization of production methodologies, to the implementation of a rigorous inter-disciplinary program of bio-research designed to support products based only upon relevant and repeatable science.”
FutureCeuticals has a long and distinguished track record in developing, manufacturing, and launching its own consumer health products, as well as hundreds of nutritional supplement and functional food ingredients used by many other manufacturers of nutrition and health-based products. They have collaborated with many major international companies in the research and development of dozens of consumer food and nutritional products in approximately 20 different product categories including baby foods, dairy products, breakfast cereals, fruit and vegetable products, and dietary supplements. Their intellectual property portfolio includes some 30 trademarked brands and over 50 patents.
Health2o recently engaged the services of Dr. Robert A. Newman, a nationally recognized nutritionist and scientist, to serve as a consultant and work closely with the selection, design, analyses, and interpretation of analytical and pharmacology studies to be performed by the scientists at FutureCeuticals. “I look forward to the careful, in-depth research of this fascinating product in order to understand its full potential in the support of human health.” said Dr. Newman. “The level of interaction and cooperation between Health2o and FutureCeuticals in fully exploring the science and promise of the Archaea Active product is to be applauded.”
07
Dec
NATIONALLY-RECOGNIZED CANCER RESEARCHER TO ADVISE HEALTH2O PRODUCTS
Posted By: Trey White - Founder and Chairman on Dec 07, 2009 in Archaea Active, Evolv, Health, news, research, Science, Trey White
GREAT news! Announced today from our friends at Health2o Products, our manufacturing partner.
Nationally-Recognized Cancer Researcher to Advise Health2o Products
DALLAS, TX (December 7, 2009)—Dr. Robert Newman, a renowned medical researcher and Professor Emeritus at a world renowned research facility, has agreed to consult with Health2o Products, LLC in regards to further testing of its Archaea Active™ formula.
Dr. Newman, currently Chief Science Officer (CSO) at a major New England nutraceutical company, will advise on future testing procedures and review and analyze test results from outside independent labs selected by Health2o.
Dr. Newman’s career has been dedicated to the development of novel therapeutic strategies to improve the quality of life for patients with inflammatory and malignant diseases. His research efforts are nationally-recognized, and have been accomplished through several scientific disciplines, including pharmacology, analytical chemistry, drug development and clinical pharmacology. His work has resulted in more than 300 peer-reviewed publications.
Dr. Newman recently retired, following a 24-year career there and over 30 years in academic medicine. He served as the Founder and Co-Director of the Pharmaceutical Development Center. Dr. Newman obtained his M.S. and Ph.D degrees in Pharmacology and Toxicology from the University of Connecticut. He was a member of the University of Vermont Medical School for seven years and was later recruited to be head of the Section of Pharmacology at a world renowned research facility where was promoted to Professor in 1991 with tenure.
“We are very pleased that Dr. Newman has signed a consulting agreement with us to serve as a Senior Advisor. He will be assisting our company in developing a road map for the continuing research and analysis of our Archaea Active™ formula,” said Kevin D. Kuykendall, chairman and CEO of Health2o Products, LLC.
Hey folks! The stories about the Evolv product are already pouring in. We knew it would happen! Keep them coming!
However, PLEASE, please, send any health-related comments and stories directly to experience@evolvhealth.com and do not publish anywhere else, otherwise you may jeopardize your business. When we receive to our email, we can have our legal eagles review them to be sure we comply with what are very strict regulations about medical claims. We may contact you after that to discuss how we can get your story out but stay within guidelines. (Posts to Facebook and Evolv web properties outside the guidelines will be deleted.)
We (and you per your distributor agreement) are prohibited from publishing health claims beyond what you see on our web site. This is very important and you will continue to hear this from us again and again.
Lastly, protect your business by reporting unapproved health claims when you see them on the Internet and elsewhere. If we work together, we can reduce regulatory risk, help others and continue to build a great business with this amazing product.
We truly appreciate everyone’s enthusiasm about Evolv.
09
Oct
An interview with Dr. Jay Collins
Posted By: Jonathan Gilliam - Chief Marketing Officer on Oct 09, 2009 in Archaea Active, Evolv, Health, research, Science
A recent interview with Jay Collins, co-inventor of the Archaea Active formula. We all love Dr. Jay – full of wit and wisdom, he inspires us all. Thanks Dr. Jay for helping create the gift of Evolv.
09
Sep
Explaining Evolv’s M.D. Anderson connection
Posted By: Jonathan Gilliam - Chief Marketing Officer on Sep 09, 2009 in Archaea Active, research, Science
Many Evolvers are interested in the Evolv product’s history and connection with The University of Texas M.D. Anderson Cancer Center. And for good reason- M.D. Anderson is a world-renowned medical institution in the field of cancer treatment and research. In 2009, U.S. News & World Report’s “America’s Best Hospitals” survey ranked M. D. Anderson as the top hospital in the nation for cancer care. M.D. Anderson has achieved the top ranking six times in the past eight years and has ranked as one of the top two hospitals for cancer care for 20 years, since the magazine began its annual survey in 1990.
With the launching of Evolv and the advent of so many Members who will soon become associated with the sale of the product, it is important that all Evolvers understand the association between EvolvHealth LLC, Health2o Products, LLC and M. D. Anderson.
Early in the life of what is now the Evolv product, Health2o Products, LLC (our manufacturing company) chose M.D. Anderson’s analytics analytical laboratory to conduct analytical tests due to its position as the best testing center in the nation to identify and quantify the active molecules in the water and the biobase starting material.
Of course, this testing is done completely independently. M. D. Anderson provides sophisticated testing and analysis of materials sent to their analytical laboratory and provides test results to HealtH2O Products, LLC and has no association, ownership or financial interest in or with HealtH2O Products, LLC or EvolvHealth LLC.
MD Anderson and its employees do not endorse Evolv as they are precluded from endorsing any product using the MD Anderson name. Our test results are just that, and are not an endorsement or backing of M.D. Anderson.
The Evolv management feels extremely blessed and fortunate that an institution the caliber of M.D. Anderson has tested our product.
